Molecular markers to predict outcome to antiangiogenic therapies in colorectal cancer: current evidence and future perspectives.

Custodio, Ana

Molecular markers to predict outcome to antiangiogenic therapies in colorectal cancer: current evidence and future perspectives. [electronic resource] - Cancer treatment reviews Dec 2013 - 908-24 p. digital

Publication Type: Journal Article; Review

1532-1967

10.1016/j.ctrv.2013.02.004 doi


Angiogenesis Inhibitors--therapeutic use
Antibodies, Monoclonal--therapeutic use
Biomarkers, Tumor--analysis
Clinical Trials as Topic
Colorectal Neoplasms--blood supply
Humans
Treatment Outcome